Danielle Antalffy
Stock Analyst at UBS
(3.47)
# 928
Out of 5,008 analysts
180
Total ratings
48.57%
Success rate
5.13%
Average return
Main Sectors:
Stocks Rated by Danielle Antalffy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Downgrades: Neutral | $230 → $89 | $76.82 | +15.86% | 7 | Sep 22, 2025 | |
| MDT Medtronic | Maintains: Neutral | $94 → $95 | $98.33 | -3.39% | 11 | Aug 20, 2025 | |
| TMCI Treace Medical Concepts | Maintains: Neutral | $8.6 → $6.5 | $6.00 | +8.33% | 7 | Aug 8, 2025 | |
| RXST RxSight | Maintains: Neutral | $16 → $8 | $8.28 | -3.38% | 4 | Aug 8, 2025 | |
| ENOV Enovis | Maintains: Buy | $65 → $57 | $30.33 | +87.93% | 2 | Aug 8, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Sell | $91 → $96 | $99.06 | -3.09% | 5 | Aug 8, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Neutral | $20 → $17 | $14.52 | +17.08% | 15 | Aug 7, 2025 | |
| BAX Baxter International | Maintains: Neutral | $35 → $24 | $22.90 | +4.80% | 6 | Aug 4, 2025 | |
| GKOS Glaukos | Maintains: Buy | $125 → $134 | $84.09 | +59.35% | 2 | Jul 31, 2025 | |
| DXCM DexCom | Maintains: Buy | $105 → $106 | $66.03 | +60.53% | 9 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $135 | $95.90 | +40.77% | 13 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $547 → $585 | $440.94 | +32.67% | 2 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $190 | $188.89 | +0.59% | 5 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $34.13 | +69.94% | 13 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $19 → $16 | $15.03 | +8.12% | 4 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5.5 → $5 | $3.47 | +44.09% | 2 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $146 → $148 | $133.02 | +11.26% | 12 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $366 → $370 | $369.24 | +0.21% | 6 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $75 | $76.72 | -2.24% | 12 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $2.25 | $2.50 | -10.00% | 1 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $280 | $313.45 | -10.67% | 12 | May 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $975 → $825 | $15.01 | +5,396.34% | 2 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $14 | $16.90 | -17.16% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $100 | $51.84 | +92.90% | 2 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $12 | $10.65 | +12.68% | 3 | Mar 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $25 → $30 | $34.61 | -13.32% | 3 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $40 → $45 | $33.11 | +35.91% | 4 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $270 → $275 | $192.53 | +42.83% | 1 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $26 → $20 | $4.13 | +384.26% | 3 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $72 → $42 | $8.59 | +388.94% | 7 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $3 | $0.47 | +539.11% | 3 | Apr 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $15 | $0.95 | +1,486.80% | 1 | Sep 1, 2020 |
Inspire Medical Systems
Sep 22, 2025
Downgrades: Neutral
Price Target: $230 → $89
Current: $76.82
Upside: +15.86%
Medtronic
Aug 20, 2025
Maintains: Neutral
Price Target: $94 → $95
Current: $98.33
Upside: -3.39%
Treace Medical Concepts
Aug 8, 2025
Maintains: Neutral
Price Target: $8.6 → $6.5
Current: $6.00
Upside: +8.33%
RxSight
Aug 8, 2025
Maintains: Neutral
Price Target: $16 → $8
Current: $8.28
Upside: -3.38%
Enovis
Aug 8, 2025
Maintains: Buy
Price Target: $65 → $57
Current: $30.33
Upside: +87.93%
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Sell
Price Target: $91 → $96
Current: $99.06
Upside: -3.09%
Tandem Diabetes Care
Aug 7, 2025
Maintains: Neutral
Price Target: $20 → $17
Current: $14.52
Upside: +17.08%
Baxter International
Aug 4, 2025
Maintains: Neutral
Price Target: $35 → $24
Current: $22.90
Upside: +4.80%
Glaukos
Jul 31, 2025
Maintains: Buy
Price Target: $125 → $134
Current: $84.09
Upside: +59.35%
DexCom
Jul 31, 2025
Maintains: Buy
Price Target: $105 → $106
Current: $66.03
Upside: +60.53%
Jul 24, 2025
Maintains: Buy
Price Target: $130 → $135
Current: $95.90
Upside: +40.77%
Jul 23, 2025
Maintains: Neutral
Price Target: $547 → $585
Current: $440.94
Upside: +32.67%
Jul 17, 2025
Maintains: Buy
Price Target: $180 → $190
Current: $188.89
Upside: +0.59%
Apr 30, 2025
Maintains: Buy
Price Target: $60 → $58
Current: $34.13
Upside: +69.94%
Apr 29, 2025
Maintains: Neutral
Price Target: $19 → $16
Current: $15.03
Upside: +8.12%
Jan 27, 2025
Maintains: Buy
Price Target: $5.5 → $5
Current: $3.47
Upside: +44.09%
Jan 23, 2025
Maintains: Buy
Price Target: $146 → $148
Current: $133.02
Upside: +11.26%
Oct 30, 2024
Maintains: Neutral
Price Target: $366 → $370
Current: $369.24
Upside: +0.21%
Sep 10, 2024
Maintains: Neutral
Price Target: $90 → $75
Current: $76.72
Upside: -2.24%
Mar 29, 2023
Initiates: Neutral
Price Target: $2.25
Current: $2.50
Upside: -10.00%
May 6, 2022
Maintains: Outperform
Price Target: $300 → $280
Current: $313.45
Upside: -10.67%
May 5, 2022
Maintains: Outperform
Price Target: $975 → $825
Current: $15.01
Upside: +5,396.34%
May 5, 2022
Maintains: Outperform
Price Target: $12 → $14
Current: $16.90
Upside: -17.16%
May 2, 2022
Maintains: Outperform
Price Target: $75 → $100
Current: $51.84
Upside: +92.90%
Mar 11, 2022
Maintains: Outperform
Price Target: $15 → $12
Current: $10.65
Upside: +12.68%
Mar 9, 2022
Maintains: Outperform
Price Target: $25 → $30
Current: $34.61
Upside: -13.32%
Feb 25, 2022
Maintains: Outperform
Price Target: $40 → $45
Current: $33.11
Upside: +35.91%
Feb 4, 2022
Maintains: Market Perform
Price Target: $270 → $275
Current: $192.53
Upside: +42.83%
Nov 10, 2021
Maintains: Outperform
Price Target: $26 → $20
Current: $4.13
Upside: +384.26%
Nov 5, 2021
Maintains: Market Perform
Price Target: $72 → $42
Current: $8.59
Upside: +388.94%
Apr 1, 2021
Downgrades: Market Perform
Price Target: $3
Current: $0.47
Upside: +539.11%
Sep 1, 2020
Initiates: Outperform
Price Target: $15
Current: $0.95
Upside: +1,486.80%